Now on Pharmaceutical Processing
California ePedigree Push to 2015 – What does it mean? Comments
Addressing the Challenges Contract Manufacturing Organizations are... Comments
From a vision to a vial in 12 months - Process development and... Comments

Subscribe to Pharmaceutical Processing
 






























 

KOWA Company, Ltd. Nagoya Factory, Building H, Nagoya, Japan

Facility Considerations
KOWA Company’s Nagoya Project features a new addition to its manufacturing plant for oral solid dosage products. Founded in 1947, KOWA is the pharmaceutical division of the KOWA Group of Companies with 3,000 employees. The new addition employs state-of-the-art isolation and containment technologies and a sophisticated automated materials handling system, and is Asia’s first application of “Lhoest” manufacturing design principles.

Professor W J Lhoest is a pharmaceutical plant design specialist and the former Director of European Manufacturing Services with SmithKline Beecham. His design principles rest on the theory that rationalization has to occur in the pharmaceutical industry. In a paper he authored in 2000 he stated that, “rationalization means a combination of efforts in multiple directions: simplification of manufacturing systems, a reduction of the production cycle time, a decrease in the number of different raw materials and also the number of commercial presentations, rationalization of packaging formats, optimization of batch sizes, a drastic simplification of the paperwork, elimination of staging, automation of material handling, and the clever but reasonable use of computers.”

KOWA set out to construct a model factory by applying these “Lhoest Concepts” to enable them to manufacture products of high quality with flexibility and low costs.



Processes/Manufacturing Equipment Employed
Key technologies adopted

-Segregation of operators, maintenance engineers
- Segregation of air flow for each process
- Gravity flow by Elveco type “Docking station
- Island idea in production space
- Fully automated material handling
- Two automated warehouses fully integrated with production

Results

High quality conforming to cGMP, EU-GMP and J-GMP

Complete elimination of cross contamination by segregation of:
- related personnel (operators, maintenance engineers, guests etc.)
- air flow of each process room
- Adoption of automated material handling system to reduce human error and contamination caused by operators
- Real time quality monitoring of purified water
- High containment material transportation adopting Elveco type "Docking Station" - first time in Japan
- level of containment never achieved before.

Flexible production and easy expansion of lines without disruption of the process
- Adoption of the idea of "Islands" for process units
- Segregation of air flow of each process room
- Adoption of automated material handling system

Low manufacturing cost
- Minimize "Clean Room" space
- Reduction of HVAC operating cost by saving energy
- Adoption of automated material handling system to save labor costs



Kowa Pharmaceuticals
6-29 Nikniki 3 Chome, Naka Ku
Nogoya, 460-0003




 
Digital Library




























Bioscience Technology Chromatography Techniques Drug Discovery & Development Laboratory Equipment Pharmaceutical Processing R&D Scientific Computing
Advantage Business Media © Copyright 2008 Advantage Business Media
Privacy Policy | Terms & Conditions | Advertise With Us